Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website

Immunic Inc.

Immunic Inc. reported $4.29M in Selling and Administration Expenses for its fiscal quarter ending in March of 2023.

Selling And Administration Expenses Change
BioMarin Pharmaceutical BMRN:US USD 223M 22.74M
Dynavax Technologies DVAX:US USD 36.54M 6.16M
Enanta Pharmaceuticals ENTA:US USD 13.78M 1.08M
Immunic Inc. VTL:US USD 4.29M 666K
Insmed INSM:US USD 79.91M 6.44M
Intercept Pharmaceuticals ICPT:US USD 57.66M 2.37M
Mirati Therapeutics MRTX:US USD 73.49M 2.67M
OraSure Technologies OSUR:US USD 27.82M 512K
Quidel QDEL:US USD 202.4M 11.2M
Regulus Therapeutics RGLS:US USD 2.44M 225K
Revance Therapeutics RVNC:US USD 63.87M 324K
Ultragenyx Pharmaceutical RARE:US USD 76.65M 3.8M
United Therapeutics UTHR:US USD 87.3M 64.7M
Xoma XOMA:US USD 6.2M 1.38M